Empfehlung
16,9
Stark Verkaufen
Composite Score (0–100)
Insider (25%)
0
Keine Insider-Käufe
Institutionell (22,5%)
29.3
Keine neuen Positionen
Aktivist (12,5%)
0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,72% (Stand: 28.02.2026)
Score-Verlauf (90 Tage)
Stammdaten
Unternehmen
| Name | Merck & Co., Inc. |
|---|---|
| Ticker | MRK |
| CIK | 0000310158 |
Branche
| SIC-Code | 2834 |
|---|---|
| Beschreibung | Pharmaceutical Preparations |
Wertpapier
| CUSIP | 29384C908 |
|---|---|
| ISIN | US29384C9083 |
| Typ | Common Stock |
| Titel | ENTRADA THERAPEUTICS INC |
Status
| Zuletzt geprüft | 2026-03-20 22:22:49.039243 |
|---|
Fondsaktivität (letzte 3 Quartale)
| Fonds | Aktuell (Stk) | Vorquartal (Stk) | Veränderung (Stk) | Wert (USD) | Status | Δ | Trend |
|---|---|---|---|---|---|---|---|
| Merck & Co., Inc. | 2,953,894 | 4,103,239 | -1,149,345 | 23,676,196 | Reduziert | -28,0% | |
| Shay Capital LLC | 2,548,730 | 0 | 2,548,730 | 3,976,019 | Neu | +100,0% | |
| Redmile Group, LLC | 2,074,372 | 2,074,372 | 0 | 3,236,020 | Unverändert | 0,0% | |
| GTS SECURITIES LLC | 200,000 | 0 | 200,000 | 312,000 | Neu | +100,0% | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 154,300 | 0 | 154,300 | 240,708 | Neu | +100,0% | |
| Pathway Financial Advisors LLC | 102,500 | 0 | 102,500 | 135,300 | Neu | +100,0% | |
| BNP PARIBAS FINANCIAL MARKETS | 46,900 | 0 | 46,900 | 61,908 | Neu | +100,0% | |
| XTX Topco Ltd | 21,727 | 0 | 21,727 | 33,894 | Neu | +100,0% | |
| UBS Group AG | 15,871 | 16,380 | -509 | 24,759 | Reduziert | -3,1% | |
| TORNO CAPITAL, LLC | 15,000 | 0 | 15,000 | 23,400 | Neu | +100,0% | |
| GEODE CAPITAL MANAGEMENT, LLC | 14,170 | 14,170 | 0 | 22,105 | Unverändert | 0,0% | |
| JANE STREET GROUP, LLC | 12,500 | 0 | 12,500 | 19,500 | Neu | +100,0% | |
| MORGAN STANLEY | 11,600 | 0 | 11,600 | 15,312 | Neu | +100,0% | |
| SIMPLEX TRADING, LLC | 100 | 5,600 | -5,500 | 1,028 | Reduziert | -98,2% | |
| SBI Securities Co., Ltd. | 300 | 300 | 0 | 468 | Unverändert | 0,0% | |
| Smallwood Wealth Investment Management, LLC | 26 | 0 | 26 | 40 | Neu | +100,0% | |
| RHUMBLINE ADVISERS | 2 | 2 | 0 | 7 | Unverändert | 0,0% | |
| TSFG, LLC | 400 | 400 | 0 | 1 | Unverändert | 0,0% |
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-02-12 | Guindo Chirfi | Officer, Chief Marketing Officer | Open Market Sale | -10,000 | 121.46 | -1,214,562.00 | -54,4% | |
| 2026-02-12 | Guindo Chirfi | Officer, Chief Marketing Officer | Open Market Sale | -10,000 | 121.46 | -1,214,562.00 | -54,4% | |
| 2026-02-10 | Li Dean Y | Officer, Executive VP & President, MRL | Open Market Sale | -10,235 | 117.52 | -1,202,843.81 | -53,9% | |
| 2026-02-10 | Li Dean Y | Officer, Executive VP & President, MRL | Open Market Sale | -10,235 | 117.52 | -1,202,843.81 | -53,9% | |
| 2026-02-09 | Zachary Jennifer | Officer, EVP, General Counsel | Open Market Sale | -38,835 | 119.15 | -4,627,275.69 | -207,4% | |
| 2026-02-09 | Guindo Chirfi | Officer, Chief Marketing Officer | Open Market Sale | -10,000 | 118.41 | -1,184,101.00 | -53,1% | |
| 2026-02-09 | Guindo Chirfi | Officer, Chief Marketing Officer | Open Market Sale | -10,000 | 118.41 | -1,184,101.00 | -53,1% | |
| 2026-02-09 | Zachary Jennifer | Officer, EVP, General Counsel | Open Market Sale | -38,835 | 119.15 | -4,627,275.69 | -207,4% | |
| 2026-02-09 | Zachary Jennifer | Officer, EVP, General Counsel | Open Market Sale | -56,792 | 119.15 | -6,766,891.74 | -303,3% | |
| 2026-02-09 | Zachary Jennifer | Officer, EVP, General Counsel | Open Market Sale | -25,946 | 119.15 | -3,091,522.98 | -138,6% | |
| 2026-02-09 | Zachary Jennifer | Officer, EVP, General Counsel | Open Market Sale | -25,946 | 119.15 | -3,091,522.98 | -138,6% | |
| 2026-02-09 | Zachary Jennifer | Officer, EVP, General Counsel | Open Market Sale | -56,792 | 119.15 | -6,766,891.74 | -303,3% | |
| 2026-02-06 | Williams David Michael | Officer, EVP,Chief Info&Digital Officer | Open Market Sale | -5,000 | 121.91 | -609,525.00 | -27,3% | |
| 2026-02-06 | Oosthuizen Johannes Jacobus | Officer, President, U.S. Market | Open Market Sale | -15,000 | 121.87 | -1,827,991.50 | -81,9% | |
| 2026-02-06 | Williams David Michael | Officer, EVP,Chief Info&Digital Officer | Open Market Sale | -5,000 | 121.91 | -609,525.00 | -27,3% | |
| 2026-02-06 | Oosthuizen Johannes Jacobus | Officer, President, U.S. Market | Open Market Sale | -15,000 | 121.87 | -1,827,991.50 | -81,9% | |
| 2026-02-06 | DeLuca Richard R. | Officer, EVP&Pres, Merck Animal Heallth | Open Market Sale | -37,685 | 120.92 | -4,557,024.71 | -204,3% | |
| 2026-02-06 | DeLuca Richard R. | Officer, EVP&Pres, Merck Animal Heallth | Open Market Sale | -37,685 | 120.92 | -4,557,024.71 | -204,3% | |
| 2026-02-05 | Guindo Chirfi | Officer, Chief Marketing Officer | Open Market Sale | -20,000 | 121.88 | -2,437,676.00 | -109,3% | |
| 2026-02-05 | Guindo Chirfi | Officer, Chief Marketing Officer | Open Market Sale | -20,000 | 121.88 | -2,437,676.00 | -109,3% | |
| 2026-02-04 | Smart Dalton E. III | Officer, SVP Fin. - Global Controller | Open Market Sale | -4,000 | 119.68 | -478,700.00 | -21,5% | |
| 2026-02-04 | Smart Dalton E. III | Officer, SVP Fin. - Global Controller | Open Market Sale | -2,400 | 119.68 | -287,220.00 | -12,9% | |
| 2026-02-04 | Davis Robert M | Director, Officer, Chairman, CEO & President | Open Market Sale | -14,972 | 117.38 | -1,757,407.37 | -78,8% | |
| 2026-02-04 | Davis Robert M | Director, Officer, Chairman, CEO & President | Open Market Sale | -32,462 | 118.35 | -3,841,919.90 | -172,2% | |
| 2026-02-04 | Li Dean Y | Officer, Executive VP & President, MRL | Open Market Sale | -15,087 | 118.77 | -1,791,824.15 | -80,3% | |
| 2026-02-04 | Li Dean Y | Officer, Executive VP & President, MRL | Open Market Sale | -15,087 | 118.77 | -1,791,824.15 | -80,3% | |
| 2026-02-04 | Litchfield Caroline | Officer, EVP & CFO | Open Market Sale | -41,997 | 119.61 | -5,023,311.57 | -225,2% | |
| 2026-02-04 | Litchfield Caroline | Officer, EVP & CFO | Open Market Sale | -41,997 | 119.61 | -5,023,311.57 | -225,2% | |
| 2026-02-04 | Smart Dalton E. III | Officer, SVP Fin. - Global Controller | Open Market Sale | -2,400 | 119.68 | -287,220.00 | -12,9% | |
| 2026-02-04 | Smart Dalton E. III | Officer, SVP Fin. - Global Controller | Open Market Sale | -4,000 | 119.68 | -478,700.00 | -21,5% | |
| 2026-02-04 | Davis Robert M | Director, Officer, Chairman, CEO & President | Open Market Sale | -32,462 | 118.35 | -3,841,919.90 | -172,2% | |
| 2026-02-04 | Davis Robert M | Director, Officer, Chairman, CEO & President | Open Market Sale | -14,972 | 117.38 | -1,757,407.37 | -78,8% | |
| 2025-11-10 | Downing Cristal N | Officer, Chief Comm. & Public Afrs Ofcr | Open Market Sale | -7,085 | 87.00 | -616,395.00 | -27,6% | |
| 2025-11-10 | Downing Cristal N | Officer, Chief Comm. & Public Afrs Ofcr | Open Market Sale | -7,085 | 87.00 | -616,395.00 | -27,6% | |
| 2025-11-03 | Williams David Michael | Officer, EVP,Chief Info&Digital Officer | Open Market Sale | -8,614 | 83.59 | -720,039.95 | -32,3% | |
| 2025-11-03 | Williams David Michael | Officer, EVP,Chief Info&Digital Officer | Open Market Sale | -8,614 | 83.59 | -720,039.95 | -32,3% | |
| 2025-04-25 | Smart Dalton E. III | Officer, SVP Fin. - Global Controller | Open Market Sale | -4,262 | 82.76 | -352,723.12 | -15,8% | |
| 2025-04-25 | Smart Dalton E. III | Officer, SVP Fin. - Global Controller | Open Market Sale | -4,262 | 82.76 | -352,723.12 | -15,8% |
Top-Fondshalter (aktuelles Quartal)
| Fonds | Anteile | Wert (USD) | Anteil (%) |
|---|---|---|---|
| Merck & Co., Inc. | 2,953,894 | 23,676,196 | 100.00 |
| SIMPLEX TRADING, LLC | 100 | 1,028 | 0.00 |